Abstract
Celiac disease remains one of the most challenging pathologies of the small intestine. It involves multiple pathogenic pathways and there are no disease-changing pharmacological agents available against it yet. The term microbiota refers to the community of microorganisms that inhabit a particular region of the body. Normal gut microbiota has a vital role in maintaining the intestinal homeostasis and promoting health. Celiac disease is associated with microbiota alteration, especially with an increase in the number of Gram-negative bacteria and a decrease in the number of Gram-positive bacteria. There is a strong relationship between intestinal dysbiosis and celiac disease, and recent studies are aimed at determining whether the celiac disease is a risk factor for dysbiosis or dysbiosis is for celiac disease. Therefore, the aim of this review was to assess the latest findings regarding the gut microbiota and its impact on the celiac disease, including therapeutic aspects.
Similar content being viewed by others
References
Bai JC, Fried M, Corazza GR et al (2013) World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 47:121–126
Frank DN, St Amand AL, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104:13780–13785
Jandhyala SM, Talukdar R, Subramanyam C et al (2015) Role of the normal gut microbiota. World J Gastroenterol 21:8787–8803
Nagao-Kitamoto H, Kitamoto S, Kuffa P et al (2016) Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res 14:127–138
De Palma G, Capilla A, Nadal I et al (2010) Interplay between human leukocyte antigen genes and the microbial colonization process of the newborn intestine. Curr Issues Mol Biol 12:1–10
Palma GD, Capilla A, Nova E et al (2012) Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PloS One 7:e30791
Olivares M, Laparra JM, Sanz Y (2013) Host genotype, intestinal microbiota and inflammatory disorders. Br J Nutr 109:S76–S80
Olivares M, Neef A, Castillejo G et al (2015) The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut 64:406–417
Kupfer S, Jabri B (2012) Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am 22:639–660
Barker JM, Liu E (2008) Celiac disease: pathophysiology, clinical manifestations and associated autoimmune conditions. Adv Pediatr 55:349–365
Garrote JA, Gómez-González E, Bernardo D et al (2008) Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 47:S27–S32
Sarno M, Discepolo V, Troncone R et al (2015) Risk factors for celiac disease. Ital J Pediatr 41:57
Icaza-Chavez ME (2013) Gut microbiota in health and disease. Rev Gastroenterol Mex 78:240–248
Bustos Fernandez LM, Lasa JS et al (2014) Intestinal microbiota: its role in digestive diseases. J Clin Gastroenterol 48:657–666
McLean MH, Dieguez D Jr, Miller LM et al (2015) Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut 64:332–341
Carding S, Verbeke K, Vipond DT et al (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26:26191
Ou G, Hedberg M, Horstedt P, Baranov V et al (2009) Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol 104:3058–3067
Cinova J, De Palma G, Stepankova R et al (2011) Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats. PloS One 6:e16169
Kalliomaki M, Satokari R, Lahteenoja H et al (2012) Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr 54:727–732
Cheng J, Kalliomaki M, Heilig HG et al (2013) Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol 13:113
De Palma G, Kamanova J, Cinova J et al (2012) Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease. J Leukoc Biol 92:1043–1054
Sjoberg V, Sandstrom O, Hedberg M et al (2013) Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria. PloS One 8:e53414
Hawrelak J, Myers S (2004) The causes of intestinal dysbiosis: a review. Altern Med Rev 9:180–197
Marild K, Ye W, Lebwohl B et al (2013) Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol 13:109
Galipeau HJ, McCarville JL, Huebener S et al (2015) Intestinal microbiota modulates gluten-induced immunopathology in humanized mice. Am J Pathol 185:2969–2982
Galipeau HJ, Verdu EF (2014) Gut microbes and adverse food reactions: focus on gluten related disorders. Gut Microbes 5:594–605
Caminero A, Galipeau HJ, McCarville JL et al (2016) Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity. Gastroenterology 151:670–683
Moran C, Sheehan D, Shanahan F (2015) The small bowel microbiota. Curr Opin Gastroenterol 31:130–136
Cenit MC, Olivares M, Codoner-Franch P et al (2015) Intestinal microbiota and celiac disease: cause, consequence or co-evolution? Nutrients 7:6900–6923
Sánchez E, Nadal I, Donat E et al (2008) Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol 8:50
Sanchez E, Ribes-Koninckx C, Calabuig M et al (2012) Intestinal Staphylococcus spp. and virulent features associated with coeliac disease. J Clin Pathol 65:830–834
Collado MC, Donat E, Ribes-Koninckx C et al (2009) Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 62:264–269
Schippa S, Iebba V, Barbato M et al (2010) A distinctive ‘microbial signature’ in celiac pediatric patients. BMC Microbiol 10:175
Di Cagno R, De Angelis M, De Pasquale I et al (2011) Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol 11:219
Sanchez E, Donat E, Ribes-Koninckx C et al (2013) Duodenal-mucosal bacteria associated with celiac disease in children. Appl Environ Microbiol 79:5472–5479
Francavilla R, Ercolini D, Piccolo M et al (2014) Salivary microbiota and metabolome associated with celiac disease. Appl Environ Microbiol 80:3416–3425
Giron Fernandez-Crehuet F, Tapia-Paniagua S, Morinigo Gutierrez MA et al (2016) The duodenal microbiota composition in children with active coeliac disease is influenced by the degree of enteropathy. An Pediatr (Barc) 84:224–230
D’Argenio V, Casaburi G, Precone V et al (2016) Metagenomics reveals dysbiosis and a potentially pathogenic N. flavescens strain in duodenum of adult celiac patients. Am J Gastroenterol 111:879–890
Nistal E, Caminero A, Herran AR et al (2012) Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm Bowel Dis 18:649–656
Bonder MJ, Tigchelaar EF, Cai X et al (2016) The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med 8:45
Nistal E, Caminero A, Vivas S et al (2012) Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie 94:1724–1729
Golfetto L, de Senna FD, Hermes J et al (2014) Lower bifidobacteria counts in adult patients with celiac disease on a gluten-free diet. Arq Gastroenterol 51:139–143
Wacklin P, Laurikka P, Lindfors K et al (2014) Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet. Am J Gastroenterol 109:1933–1941
Wacklin P, Kaukinen K, Tuovinen E, et al (2013) The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 2013;19:934–941
Pozo-Rubio T, Olivares M, Nova E et al (2012) Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol 2012:654143
Pozo-Rubio TG, Mujico JR, Olivares M et al (2013) Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study. Nutr Hosp 28:464–473
Ivanov II, Honda K (2012) Intestinal commensal microbes as immune modulators. Cell Host Microbe 12:496–508
Gerald Friedman (2012) Clinical applications of probiotics in gastroenterology: questions and answers, an issue of gastroenterology clinics. Saunders, United States
Fons M, Gomez A (2000) Mechanisms of colonisation and colonisation resistance of the digestive tract. Microbial Ecol Health Dis 12:240–246
Hardy H, Harris J, Lyon E et al (2013) Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5:1869–1912
Sherman PM, Ossa JC, Johnson-Henry K (2009) Unraveling mechanisms of action of probiotics. Nutr Clin Pract 24:10–14
Iebba V, Santangelo F, Totino V et al (2013) Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects. PloS One 8:e61608
De Sousa Moraes LF, Grzeskowiak LM, de Sales Teixeira TF et al (2014) Intestinal microbiota and probiotics in celiac disease. Clin Microbiol Rev 27:482–489
Olivares M, Castillejo G, Varea V et al (2014) Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br J Nutr 112:30–40
Lorenzo Pisarello MJ, Vintini EO, Gonzalez SN et al (2015) Decrease in lactobacilli in the intestinal microbiota of celiac children with a gluten-free diet, and selection of potentially probiotic strains. Can J Microbiol 61:32–37
Klemenak M, Dolinsek J, Langerholc T et al (2015) Administration of bifidobacterium breve decreases the production of TNF-alpha in children with celiac disease. Dig Dis Sci 60:3386–3392
Wei G, Tian N, Valery AC et al (2015) Identification of pseudolysin (lasB) as an aciduric gluten-degrading enzyme with high therapeutic potential for celiac disease. Am J Gastroenterol 110:899–908
Mohammadi R, Hosseini-Safa A, Ehsani Ardakani MJ et al (2015) The relationship between intestinal parasites and some immune-mediated intestinal conditions. Gastroenterol Hepatol Bed Bench 8:123–131
Croese J, Giacomin P, Navarro S et al (2015) Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J Allergy Clin Immunol 135:508–516
Giacomin P, Zakrzewski M, Croese J et al (2015) Experimental hookworm infection and escalating gluten challenges are associated with increased microbial richness in celiac subjects. Sci Rep 5:13797
Kverka M, Tlaskalova-Hogenova H (2013) Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs. APMIS 121:403–421
Conlon AM, Bird AR (2015) The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7:17–44
De Angelis M, Vannini L, Di Cagno R et al (2016) Salivary and fecal microbiota and metabolome of celiac children under gluten-free diet. Int J Food Microbiol 19(239):125–132
Acknowledgements
The first author received a grant from the University of Medicine and Pharmacy “Iuliu Hațieganu” Cluj–Napoca 2016, project no. 4995/21/08.03.2016.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
All authors contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Girbovan, A., Sur, G., Samasca, G. et al. Dysbiosis a risk factor for celiac disease. Med Microbiol Immunol 206, 83–91 (2017). https://doi.org/10.1007/s00430-017-0496-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-017-0496-z